Gland Pharma Limited
ListedSMEHealthcare / Pharmaceuticals & Biotechnology · NSE / BSE
Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.
Price Band
₹1490 – ₹1500
Issue Size
₹6480 Cr
Lot Size
10 shares
GMP
₹118
+7.9%
Est. Listing
₹1618
at current GMP
Subscribed
—
Open
9 Nov 2020
Close
11 Nov 2020
Allotment
18 Nov 2020
Refund
19 Nov 2020
Demat Credit
20 Nov 2020
Listing
20 Nov 2020
Last updated 10 months ago
Key Highlights
- •Leading player in the Healthcare / Pharmaceuticals & Biotechnology segment
- •Price band established at ₹1490 - ₹1500 per equity share
- •Minimum bid lot is 10 shares
- •Estimated listing target of ₹1618 based on current grey market activity